Examination of Hospital Readmissions after Plastic Surgery Aims to Cut Costs, Enhance Patient Care
Postoperative Complication is Significant Predictor, Says Study in Plastic and Reconstructive Surgery
Arlington Heights, Ill. - For patients undergoing plastic and reconstructive surgery procedures, obesity, anemia and postoperative complications-especially surgical and wound complications-are independent risk factors for hospital readmission, reports a study in the September issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
"Patients experiencing postoperative surgical complications were six times more likely to be readmitted," write Dr. John P. Fischer and colleagues at the Hospital of the University of Pennsylvania, Philadelphia, in an analysis of plastic and reconstructive surgeries. "These findings can assist surgeons and health systems in better tailoring preoperative counseling, resource allocation and postoperative discharge services."
What Factors Affect Readmission Risk after Plastic Surgery?
The researchers analyzed detailed information on nearly 10,700 patients undergoing plastic and reconstructive surgical procedures during 2011, drawn from an American College of Surgeons database. The patients' average age was 49.5 years; about 80 percent were women. Most patients were undergoing some type of breast surgery, including elective/ cosmetic breast surgery, breast reconstruction or revision breast procedures.
The overall rate of hospital readmission within 30 days after surgery was 4.5 percent. Certain types of operations such as elective/cosmetic plastic surgery and hand surgery were associated with lower readmission rates. Patients undergoing more complex procedures-especially muscle flaps, wound debridement, or autologous reconstruction procedures-were more likely to be readmitted.
Most of the patients were healthy, although 32 percent were obese and 18 percent had anemia. After adjustment for other factors, both of these health factors were associated with an increase in readmission risk: by 20 percent for obese patients and 80 percent for those with anemia.
Surgical and Wound Complications Bring Sharp Increases in Risk
Patients with any type of postoperative complication had the greatest increase in readmission. The overall complication rate was about 11 percent, including nearly a five percent rate of major surgical complications.
After adjusted analysis, risk of readmission was six times higher for patients with surgery-related complications and five times higher for those with wound-related complications. Patients with complications related to medical conditions also had a twofold increase in readmission risk.
Unplanned hospital admissions after surgery have become an important indicator of the quality and excess costs of healthcare. "Readmission following surgical procedures can be common and extremely costly for healthcare systems," according to Dr. Fischer and coauthors. The new analysis is one of the first large studies to focus on the risks of readmission after plastic surgery.
The results highlight specific types of plastic and reconstructive surgical procedures associated with an increased risk of rehospitalization. Although obesity and anemia are important contributors, the "critical finding" is the increased readmission risk associated with postoperative complications.
Dr. Fischer and colleagues hope their results will inform efforts to lower readmission rates in high-risk groups of plastic and reconstructive surgery patients. They write, "These findings highlight the importance of early recognition of complication, careful preoperative patient selection and counseling, and early intervention and close follow-up in higher risk cohorts." Such efforts may become especially important as hospitals face possible financial consequences related to "unplanned readmissions" under health care reform.
Plastic and Reconstructive Surgery® is published by Lippincott Williams & Wilkins, part of Wolters Kluwer Health.
About Plastic and Reconstructive Surgery
For over 75 years, Plastic and Reconstructive Surgery® has been the one consistently excellent reference for every specialist who uses plastic surgery techniques or works in conjunction with a plastic surgeon. The official journal of the American Society of Plastic Surgeons, Plastic and Reconstructive Surgery® brings subscribers up-to-the-minute reports on the latest techniques and follow-up for all areas of plastic and reconstructive surgery, including breast reconstruction, experimental studies, maxillofacial reconstruction, hand and microsurgery, burn repair and cosmetic surgery, as well as news on medico-legal issues.
The American Society of Plastic Surgeons (ASPS) is the largest organization of board-certified plastic surgeons in the world. Representing more than 7,000 physician members, the society is recognized as a leading authority and information source on cosmetic and reconstructive plastic surgery. ASPS comprises more than 93 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada.
About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions and services for the clinicians, nurses, accountants, lawyers and tax, finance, audit, risk, compliance and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.
Wolters Kluwer reported 2020 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,200 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.